Fluciclovine F-18

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

Prostate Imaging-PET: 18F-Fluciclovine (Axumin).

Prostate Imaging-PET: 18F-Fluciclovine (Axumin).

Journal: Journal of nuclear medicine technology

Published: March 09, 2026

18F-Fluciclovine PET enables accurate and safe resection of malignant brain tumors: illustrative cases.

18F-Fluciclovine PET enables accurate and safe resection of malignant brain tumors: illustrative cases.

Journal: Journal of neurosurgery. Case lessons

Published: September 08, 2025

Clinical Practice Guidelines for 18F-Fluciclovine 2024 in the Japanese Society of Nuclear Medicine.

Clinical Practice Guidelines for 18F-Fluciclovine 2024 in the Japanese Society of Nuclear Medicine.

Journal: Annals of nuclear medicine

Published: June 28, 2025

Cost-Effectiveness Modeling of Prostate-Specific Membrane Antigen Positron Emission Tomography with Piflufolastat F 18 for the Initial Diagnosis of Patients with Prostate Cancer in the United States.

Cost-Effectiveness Modeling of Prostate-Specific Membrane Antigen Positron Emission Tomography with Piflufolastat F 18 for the Initial Diagnosis of Patients with Prostate Cancer in the United States.

Journal: PharmacoEconomics

Published: October 01, 2023

18F-Fluciclovine Uptake in an Incidentally Discovered Meningioma in a Patient With a History of Metastatic Prostate Cancer: A Case Report.

18F-Fluciclovine Uptake in an Incidentally Discovered Meningioma in a Patient With a History of Metastatic Prostate Cancer: A Case Report.

Journal: Cureus

Published: September 27, 2023

Tracing prostate cancer - the evolution of PET-CT applications.

Tracing prostate cancer - the evolution of PET-CT applications.

Journal: Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology

Published: July 15, 2023

Treatment Response to Lycopene in Recurrent Prostate Cancer Confirmed on 18 F-Fluciclovine PET/CT.

Treatment Response to Lycopene in Recurrent Prostate Cancer Confirmed on 18 F-Fluciclovine PET/CT.

Journal: Clinical nuclear medicine

Published: February 02, 2023

Complementary Role of 18 F-Fluciclovine PET/CT and 18 F-NaF PET/CT in Detecting Prostate Cancer Metastasis.

Complementary Role of 18 F-Fluciclovine PET/CT and 18 F-NaF PET/CT in Detecting Prostate Cancer Metastasis.

Journal: Clinical nuclear medicine

Published: January 30, 2023

Prostate Cancer-PET Imaging Update.

Prostate Cancer-PET Imaging Update.

Journal: Cancers

Published: January 02, 2023

Management Impact of Metachronous Oligometastatic Disease Identified on 18F-Fluciclovine (Axumin™) PET/CT in Biochemically Recurrent Prostate Cancer.

Management Impact of Metachronous Oligometastatic Disease Identified on 18F-Fluciclovine (Axumin™) PET/CT in Biochemically Recurrent Prostate Cancer.

Journal: Molecular imaging and biology

Published: March 10, 2022

Incidental Uptake of 18F-Fluciclovine by Type AB Thymoma.

Incidental Uptake of 18F-Fluciclovine by Type AB Thymoma.

Journal: Clinical nuclear medicine

Published: January 10, 2022

Comparison of [18F]fluciclovine and [18F]FDG PET/CT in Newly Diagnosed Multiple Myeloma Patients.

Comparison of [18F]fluciclovine and [18F]FDG PET/CT in Newly Diagnosed Multiple Myeloma Patients.

Journal: Molecular imaging and biology

Published: January 03, 2022

Showing 1-12 of 41

Last Updated: 04/28/2026